Expanded carrier screening: Too much of a good thing?

Prenatal Diagnosis

Volumn 35, Issue 10, 2015, Pages 936-937

  Rose, Nancy C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; CYSTIC FIBROSIS; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENE SEQUENCE; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEMOGLOBINOPATHY; HETEROZYGOTE; HUMAN; NEWBORN SCREENING; PATIENT EDUCATION; PENETRANCE; PHENOTYPIC VARIATION; PHENYLKETONURIA; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; TAY SACHS DISEASE; HETEROZYGOTE DETECTION;

HETEROZYGOTE DETECTION; HUMANS; PRENATAL DIAGNOSIS;

EID: 84943364923     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4638     Document Type: Editorial

References (9)

1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963;32:338-43.
2. Kaback M. Population-based genetic screening for reproductive counseling: the Tay-Sachs disease model. Eur J Pediatr 2000;159:S192-5.
3. Wald NJ. Guidance on terminology. J Med Screen 2001;8:56.
4. American College of Obstetricians and Gynecologists. Update on carrier screening for cystic fibrosis Committee Opinion No 235. Obstet Gynecol 2011;106(6):1465-8.
5. Grody WW, Thompson BH, Gregg AR, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med 2013; 15(8):482-3.
6. Edwards JG, Feldman G, Goldberg J, et al. Expanded carrier screening in reproductive medicine: points to consider-a joint statement of the American College of Medical Genetics and Genomics, American College of Obstetricians and Gynecologists, National Society of Genetic Counselors, Perinatal Quality Foundation, and Society for Maternal-Fetal Medicine. Obstet Gynecol 2015;125:653-62.
7. Hickey SH, Curry CJ, Toriello HV. ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet Med 2013;15(2):153-6.
8. Lazarin GA, Haque IS, Nazareth S, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23, 453 individuals. Genet Med 2013;15(3):178-86
9. Laberge A, Psaty BM, Hindorff LA, Burke W. Use of Factor V Leiden genetic testing in practice and impact on management. Genet Med 2009;11(10):750-6. doi:10.1097/GIM.0b013e3181b3a697.